Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Old Tech Earnings Preview: What to Expect From IBM, Intel Reports?

Published 01/25/2024, 12:16 AM
Updated 07/09/2023, 06:31 AM

IBM (NYSE:IBM) last made a new all-time high over 10 years ago, around $213 – $215 in April 2013. Intel’s last all-time high was September 2000, when it hit $75.81 per share.

Here’s the performance of both stocks versus the S&P 500 since 1/1/2000:IBM and INTC vs SPX Total Return

For performance-sensitive readers, that’s brutal.

IBM: Technical analysis portends better growth for Big BlueINTC-Monthly Chart

This monthly chart of IBM shows a significant break in the trendline in the stock beginning in Q4 ’23.

Tonight, IBM is expected to report $17.3 billion in revenue and $3.78 in EPS, which is 4% and 5% yoy growth respectively for IBM.

The 4th quarter of every year is typically IBM’s strongest quarter of the year.

F04 2024, the current sell-side consensus is currently expecting 4% EPS growth and 3% revenue growth, so the sudden improvement in the stock price has not yet been driven by dramatic earnings or revenue improvement.

When looking at IBM’s business segments, (and it’s just an opinion), but Big Blue seems to moving closer and closer to a software firm. Morningstar has noted that the consulting business looks to be a decent long-term business, but RedHat is probably maxed out in terms of its potential (James Whitehead, RedHat’s CEO who moved over to IBM when IBM bought RedHat, has already left as of a few years ago), but’s it’s still a guess as to what IBM will look like in 5 years. Big Iron seems to be long gone for the former mainframe giant, but will software be the primary revenue driver in 2029 – 2030?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

One of the more positive data points about IBM, looking at the estimates is that after 4 years of negative revenue growth (and this doesn’t adjust for the Kyndryl spinoff), low-single-digit revenue growth is expected in the next 3 years.

IBM has been shrinking for years and got even smaller with the Kyndryl spinoff.

IBM hasn’t bought back any stock in 13 quarters, even though free cash flow has started to stabilize around the $9 – $10 billion annual run rate at IBM, with the dividend consuming $6 billion a year. Maybe Big Blue will announce tonight a resumption of the share buyback program tonight.

Valuation: With the stock trading at roughly 16x – 18x earnings, for expected EPS growth from ’24 – ’26 averaging 6% – 10%, the multiple is not daunting, but the important metric from an “estimate” perspective, is expected low-single-digit revenue growth the next few years. Price-to-cash-flow and free-cash-flow is 12x and 14x. The dividend yield is just under 4% with the stock trading at $175 per share.

Conclusion:

Finally (maybe) Big Blue can generate some sustainable albeit low single-digit revenue growth the next few years. Let’s see if there is improved guidance or some fundamental improvement in the company’s fundamentals to warrant the increase in the stock price in the last few months. Big Blue has a history of being out of favor for years, and then catching a tail-wind. Maybe IBM has found a way to capture some of the AI frenzy.

Intel: Intel (NASDAQ:INTC) reports after the close Thursday night and sell-side consensus and analysts expect $15.1 billion in revenue to generate $0.45 in EPS for expected yoy growth of 8% and +350% respectively. Q4 ’22 is an easy compare for Intel when it generated a 41% and 91% revenue and EPS decline respectively.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Q3 ’23 saw INTC beat on EPS by 42% ($0.41 actual vs the $0.22 estimate), and a 4% revenue beat. With a manufacturing-heavy plant base, and all that operating leverage, the 4% revenue beat is just as important as the 41% EPS beat, maybe more so.

The stock has had a remarkable run off its Feb ’23 lows near $25 and has almost doubled in price in 12 months.

INTC Revenue Estimate Revisions

Forward revenue and EPS estimates are expecting an average of 11% revenue growth and 61% EPS growth from ’24 to ’26, which is against the two sharply negative years of ’22 and ’23. In 2022, Intel EPS and revenue fell 66% and 16% respectively and in ’23 – of Q4 ’23 consensus is met – revenue will fall 14% and EPS will drop 48%. That’s two years of pretty ugly declines.

Intel’s average PE for ’24 to ’26 is 19x.

The sell-side consensus is clearly expecting a recovery in INTC in the next 3 years. The PC business which is 56% of revenue as of Q3 ’23 and all of Intel’s operating income, seems to be on the mend. The business I’m intrigued by – and not being an electrical engineer take it with a grain of salt – is the foundry business, which was started by Pat Gelsinger, and appears to be a beneficiary of an expected re-shoring of semiconductor manufacturing from Taiwan to the US – but it’s still just 2% of revenue, although I’ve seen a few analyst comments where Intel is adding some customers to the foundry business, perhaps at a pace that is faster-than-expected.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

My big worry with INTC is that it generated a negative $10 billion in free cash flow on a trailing twelve-month basis as of 9/30/23. Pat Gelsinger and the management team have had to add manufacturing capacity at a time when they are most financially constrained.

Capex has exceeded “cash-flow-from-operations” for 6 consecutive quarters.

That’s painful for a capex-heavy business.

Intel obviously hasn’t bought back any stock in a while – 9 quarters – and they’ve cut the dividend to take some pressure off and restore some free cash flow.

When looking at the results Thursday night, “revenue upside” is more valuable for Intel here than EPS upside, but revenue upside will likely drive EPS upside.

Overall Conclusion:

Old technology like IBM and Intel are starting to stir. Good investors always teach us that “always trust price” and both stocks have seen a nice bounce in the last few months. If IBM and Arvind Krishna, can find a sustainable business model, IBM probably has more upside than Intel simply because of Intel’s operating and financial leverage, from its manufacturing footprint. That being said readers will likely get sharper selloffs in Intel given the above.

Clients own very small positions in both stocks. Growth continues to work over value, but both of these companies look to turn themselves around after brutal periods of underperformance.

***

None of this is advice or a recommendation, and past performance is no guarantee or suggestion of future results. All revenue and EPS estimates and data are sourced from the London Stock Exchange Group. Even though these two stocks are considered old tech, they are not without risk and volatility.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.